Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.6M Buy
15,478
+284
+2% +$97.2K 0.7% 29
2026
Q1
$5.3M Buy
15,194
+119
+0.8% +$42.4K 0.5% 42
2025
Q4
$4.93M Buy
15,075
+173
+1% +$54.9K 0.76% 28
2025
Q3
$4.21M Buy
14,902
+1,181
+9% +$343K 0.66% 34
2025
Q2
$3.83M Buy
+13,721
New +$3.89M 1.17% 26

Other funds holding AMGN

HORAN Wealth's AMGN Position: Q2 2026 in Review

HORAN Wealth increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $97.2K and bringing the position to 15,478 shares worth $5.6M. The position accounts for 0.7% of the portfolio, ranked #29.

HORAN Wealth first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HORAN Wealth held 15,478 shares of Amgen worth $5.6M as of Q2 2026.
  • HORAN Wealth bought 284 Amgen shares in Q2 2026, an estimated $97.2K.
  • Amgen made up 0.7% of HORAN Wealth's portfolio in Q2 2026, its #29 holding.
  • HORAN Wealth first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.